UK's CPI opens doors for SMEs at new biologics manufacturing centre
The £38m ($58m) National Biologics Manufacturing Centre has opened its doors offering bioprocessing space to SMEs in the UK.
Archives for October 1, 2015
Round 2 Amgen? US FDA accepts Sandoz's Enbrel biosimilar for review
A second Sandoz biosimilar has been accepted for review by US FDA setting the stage for another potential legal battle with Amgen.